Insider · CIK 0001263463
Melvin L Keating
Files at AGYS (AGILYSYS INC), RMCF (Rocky Mountain Chocolate Factory, Inc.). First filing Nov 12, 2024, latest Mar 18, 2026.
Melvin L Keating files SEC Form 4 as director at AGYS (AGILYSYS INC), and also at RMCF (Rocky Mountain Chocolate Factory, Inc.). Since Nov 12, 2024, Melvin L Keating has reported 2 open-market buys worth $78k and 2 open-market sells worth $1.3M, the latest filed on Mar 18, 2026.
A track record needs three past buys with six months of prices behind them; Melvin L Keating has 0, so none is measured yet.
The newest scored trade: bought $27k of AGYS on Mar 16, 2026, filed Mar 18, 2026, scored 43 (moderate). In the last 12 months: 2 buys worth $78k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AGYS: AGILYSYS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | AGYSbuy AGILYSYS INC | $27k 400 shares | +1% | +4% from low-52% from high | |
| 30Weak | AGYSbuy AGILYSYS INC | $50k 600 shares | +2% | +32% from low-39% from high | |
| 55Moderate | AGILYSYS INC | $625k 5,420 shares | -12% | - | |
| 55Moderate | AGILYSYS INC | $627k 5,180 shares | -13% | - |
Transactions
Every row this insider has filed, 28 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | RMCF Rocky Mountain Chocolate Factory, Inc. | AGrant or award Common Stock | +7,000 | $0.00 | $0 | 110,079 | 21 d ago |
| Sep 1, 2026 | RMCF Rocky Mountain Chocolate Factory, Inc. | AGrant or award Common Stock | +55,622 | $0.00 | $0 | 103,079 | 40 d ago |
| May 27, 2026 | AGYS AGILYSYS INC | AGrant or award Restricted Stock Unitsderivative | +1,424 | $0.00 | $0 | 1,424 | May 29, 2026 |
| May 22, 2026 | AGYS AGILYSYS INC | MOption exercise Common Stock | +973 | $79.84 | $78k | 36,380 | May 27, 2026 |
| May 22, 2026 | AGYS AGILYSYS INC | MOption exercise Restricted Stock Unitsderivative | -973 | $0.00 | $0 | 973 | May 27, 2026 |
| Mar 16, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +100 | $68.49 | $6,849 | 35,107 | Mar 18, 2026 |
| Mar 16, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +60 | $68.20 | $4,092 | 35,167 | Mar 18, 2026 |
| Mar 17, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +65 | $68.10 | $4,427 | 35,232 | Mar 18, 2026 |
| Mar 17, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +50 | $68.01 | $3,401 | 35,282 | Mar 18, 2026 |
| Mar 17, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +55 | $67.98 | $3,739 | 35,337 | Mar 18, 2026 |
| Mar 17, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +70 | $68.32 | $4,782 | 35,407 | Mar 18, 2026 |
| Jan 30, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +100 | $83.90 | $8,390 | 34,507 | Feb 3, 2026 |
| Jan 30, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +50 | $83.99 | $4,200 | 34,557 | Feb 3, 2026 |
| Jan 30, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +50 | $84.40 | $4,220 | 34,607 | Feb 3, 2026 |
| Jan 30, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +100 | $84.84 | $8,484 | 34,707 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +40 | $84.10 | $3,364 | 34,747 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +60 | $83.83 | $5,030 | 34,807 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +30 | $84.22 | $2,527 | 34,837 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +70 | $84.70 | $5,929 | 34,907 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +50 | $81.90 | $4,095 | 34,957 | Feb 3, 2026 |
| Feb 3, 2026 | AGYS AGILYSYS INC | POpen-market purchase Common Stock | +50 | $82.82 | $4,141 | 35,007 | Feb 3, 2026 |
| Dec 22, 2025 | RMCF Rocky Mountain Chocolate Factory, Inc. | AGrant or award Common Stock | +25,248 | $0.00 | $0 | 40,457 | Dec 22, 2025 |
| May 22, 2025 | AGYS AGILYSYS INC | AGrant or award Restricted Stock Unitsderivative | +973 | $0.00 | $0 | 973 | May 27, 2025 |
| Jan 3, 2025 | RMCF Rocky Mountain Chocolate Factory, Inc. | AGrant or award Common Stock | +15,209 | $0.00 | $0 | 15,209 | Jan 3, 2025 |
| Nov 8, 2024 | AGYS AGILYSYS INC | SOpen-market sale Common Stock | -1,900 | $118.11 | $224k | 37,687 | Nov 12, 2024 |
| Nov 6, 2024 | AGYS AGILYSYS INC | SOpen-market sale Common Stock | -3,500 | $114.19 | $400k | 41,507 | Nov 12, 2024 |
| Nov 11, 2024 | AGYS AGILYSYS INC | SOpen-market sale Common Stock | -3,280 | $122.84 | $403k | 34,407 | Nov 12, 2024 |
| Nov 7, 2024 | AGYS AGILYSYS INC | SOpen-market sale Common Stock | -1,920 | $117.55 | $226k | 39,587 | Nov 12, 2024 |
Questions about Melvin L Keating
Answered from the filings on this page, as of the latest one.
Is Melvin L Keating buying or selling?
In the last 12 months Melvin L Keating reported 2 open-market buys worth $78k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $27k of AGYS on Mar 16, 2026. Grants, option exercises and tax withholding are not counted.
How did Melvin L Keating's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Melvin L Keating has 0.
Where does Melvin L Keating file Form 4?
Melvin L Keating has filed Form 4 at AGYS (AGILYSYS INC); RMCF (Rocky Mountain Chocolate Factory, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.